Omeprazol Farmex (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Farmex, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces stomach acid production and is used to treat gastro‑reflux disease and related conditions in adults and children. GNH USA supplies Omeprazol Farmex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Farmex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Farmex is a proton pump inhibitor that acts on the acid‑secretion pathway in the gastrointestinal tract. - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease (PUD): supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑induced gastropathy: helps prevent ulcer formation in patients requiring long‑term NSAID therapy.

Omeprazol Farmex may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild, transient headache reported in clinical use. - Diarrhea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Hypomagnesemia: low serum magnesium with prolonged use. - Acute interstitial nephritis: kidney inflammation presenting with rash and renal impairment. - Stevens‑Johnson syndrome: rare severe skin reaction. - Fracture risk: possible decrease in bone mineral density with long‑term therapy. - Hepatic injury: elevated liver enzymes or hepatitis in rare cases.

When prescribing Omeprazol Farmex, clinicians should consider several safety aspects. - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: especially during long‑term therapy. - Evaluate bone health: consider calcium and vitamin D supplementation if therapy exceeds 12 months. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: use only if clearly needed; discuss risks with the patient. - Store at below 25°C: keep in the original packaging, protect from moisture and direct light.

Omeprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atorvastatin: increased plasma concentrations, raising risk of myopathy. - HIV protease inhibitors (e.g., ritonavir): decreased antiviral efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR, requiring closer monitoring. - Methotrexate: increased serum levels, especially with high‑dose regimens. - Digoxin: enhanced absorption may lead to toxicity. - Iron supplements: reduced absorption, consider timing separation.